Biocon Gets Nod To Use Cytosorb For Critical Covid-19 Patients
Biocon Gets Approval For Emergency Use Of Cytosorb To Treat Critical Covid-19 Patients. Sakshi Bajaj speaks to Chairperson of Biocon, Kiran Mazumdar Shaw on the details and usage of this device.
No comments:
Post a Comment